211 related articles for article (PubMed ID: 7675765)
21. Primary malignant lymphoma of the brain: demonstration of the p53 gene mutations by PCR-SSCP analysis and immunohistochemistry.
Koga H; Zhang S; Ichikawa T; Washiyama K; Kuroiwa T; Tanaka R; Kumanishi T
Noshuyo Byori; 1994; 11(2):151-5. PubMed ID: 7894617
[TBL] [Abstract][Full Text] [Related]
22. p53 mutation is infrequent in clear cell carcinoma of the ovary.
Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS
Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858
[TBL] [Abstract][Full Text] [Related]
23. Infrequent mutation of the p53 gene in fibrous tumors of infancy and childhood.
Boman F; Peters J; Ragge N; Triche T
Diagn Mol Pathol; 1993 Mar; 2(1):14-22. PubMed ID: 8287221
[TBL] [Abstract][Full Text] [Related]
24. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
25. Exclusion of the Wilms tumour gene (WT1) promoter as a site of frequent mutation in Wilms tumour.
Grubb GR; Yun K; Reeve AE; Eccles MR
Oncogene; 1995 Apr; 10(8):1677-81. PubMed ID: 7731725
[TBL] [Abstract][Full Text] [Related]
26. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
[TBL] [Abstract][Full Text] [Related]
27. [Correlation between p53 gene mutation and protein expression in 30 cases of human lung cancer].
Zhang J; Zheng J; Fang W
Zhonghua Yi Xue Za Zhi; 1998 Nov; 78(11):846-9. PubMed ID: 11038779
[TBL] [Abstract][Full Text] [Related]
28. p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status.
Tolbert DM; Noffsinger AE; Miller MA; DeVoe GW; Stemmermann GN; Macdonald JS; Fenoglio-Preiser CM
Mod Pathol; 1999 Jan; 12(1):54-60. PubMed ID: 9950163
[TBL] [Abstract][Full Text] [Related]
29. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
[TBL] [Abstract][Full Text] [Related]
30. Replication error phenotype and p53 gene mutation in lymphomas of mucosa-associated lymphoid tissue.
Peng H; Chen G; Du M; Singh N; Isaacson PG; Pan L
Am J Pathol; 1996 Feb; 148(2):643-8. PubMed ID: 8579126
[TBL] [Abstract][Full Text] [Related]
31. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.
Teneriello MG; Ebina M; Linnoila RI; Henry M; Nash JD; Park RC; Birrer MJ
Cancer Res; 1993 Jul; 53(13):3103-8. PubMed ID: 8319218
[TBL] [Abstract][Full Text] [Related]
32. Polymerase chain reaction-single-strand conformation polymorphism analysis for the VHL gene in chemically induced kidney tumors of rats using intron-derived primers.
Shiao YH; Diwan BA; Perantoni AO; Calvert RJ; Zbar B; Lerman MI; Rice JM
Mol Carcinog; 1997 Aug; 19(4):230-5. PubMed ID: 9290699
[TBL] [Abstract][Full Text] [Related]
33. [Detection of p53 mutation using PCR-SSCP silver staining method].
Zhao W; Si J; Li K; Zhang X; Song G
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Jun; 17(3):219-22. PubMed ID: 8706159
[TBL] [Abstract][Full Text] [Related]
34. Codon 45 of the beta-catenin gene, a specific mutational target site of Wilms' tumor.
Kusafuka T; Miao J; Kuroda S; Udatsu Y; Yoneda A
Int J Mol Med; 2002 Oct; 10(4):395-9. PubMed ID: 12239584
[TBL] [Abstract][Full Text] [Related]
35. p53 gene mutation spectrum in human unknown primary tumors.
Bar-Eli M; Abbruzzese JL; Lee-Jackson D; Frost P
Anticancer Res; 1993; 13(5A):1619-23. PubMed ID: 8239543
[TBL] [Abstract][Full Text] [Related]
36. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
[TBL] [Abstract][Full Text] [Related]
37. The same mutation affecting the splicing of WT1 gene is present on Frasier syndrome patients with or without Wilms' tumor.
Barbosa AS; Hadjiathanasiou CG; Theodoridis C; Papathanasiou A; Tar A; Merksz M; Györvári B; Sultan C; Dumas R; Jaubert F; Niaudet P; Moreira-Filho CA; Cotinot C; Fellous M
Hum Mutat; 1999; 13(2):146-53. PubMed ID: 10094551
[TBL] [Abstract][Full Text] [Related]
38. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA
Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641
[TBL] [Abstract][Full Text] [Related]
39. Molecular diagnosis of p53 mutations in gastric carcinoma by touch preparation.
Ricevuto E; Ficorella C; Fusco C; Cannita K; Tessitore A; Toniato E; Gabriele A; Frati L; Marchetti P; Gulino A; Martinotti S
Am J Pathol; 1996 Feb; 148(2):405-13. PubMed ID: 8579104
[TBL] [Abstract][Full Text] [Related]
40. P53 mutations in mammary tumor cell lines and corresponding tumor tissues in the dog.
Van Leeuwen IS; Hellmèn E; Cornelisse CJ; Van den Burgh B; Rutteman GR
Anticancer Res; 1996; 16(6B):3737-44. PubMed ID: 9042250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
